Metabolic disorders and nonunion risk after tibial shaft fracture

Polish version: Zaburzenia metaboliczne a ryzyko braku zrostu po złamaniu trzonu piszczeli

Does nonunion risk after surgical treatment of a tibial shaft fracture increase with the number of coexisting metabolic disorders? A TriNetX analysis of 36,474 patients found a stepwise association with diabetes, hypertension, obesity and dyslipidaemia. This is a clinically relevant prognostic finding, but it does not prove that treating those four diagnoses will prevent nonunion.

Why this study matters

Assessment of tibial nonunion risk usually considers fracture pattern, soft-tissue injury, infection, smoking, fixation stability and healing biology. This study asked whether common metabolic conditions also matter as a cumulative burden. Hypertension and dyslipidaemia are not usually regarded as direct determinants of union, but their coexistence may identify patients who warrant closer risk assessment, follow-up and general medical optimisation.

Study design

This retrospective cohort study used the TriNetX Research Network to identify surgically treated AO/OTA 42 tibial shaft fractures during 2013–2023. At least 1 year of follow-up was required. Patients with a previous tibial nonunion diagnosis or known metabolic bone disease were excluded.

The primary outcome was postoperative tibial shaft nonunion. Diabetes, hypertension, obesity and dyslipidaemia were analysed individually and according to the number of concurrent conditions. The 36,474 patients had a mean age of 41.5 years; 62.7% were men. The cohort thus covered a broad age range rather than a solely geriatric population.

Main results

• Diabetes had the largest association with nonunion: HR 2.82 (P < 0.001).
• HRs were 1.87 for hypertension, 1.45 for obesity and 1.25 for dyslipidaemia; all associations were statistically significant.
• In the strata reported in the public abstract, nonunion occurred in 5.0% of patients with none of these conditions, 8.5% with one, 10.4% with two and 11.8% with at least three.
• Time-to-event analysis showed a stepwise increase: HR 1.59 with one condition, 2.62 with two, 3.16 with three and 3.37 with all four.

No clear risk gradient was demonstrated across obesity classes. The public abstract contains an inconsistency between one HR and its confidence interval for BMI 30–35; that specific estimate should not be reproduced or interpreted uncritically.

Clinical interpretation for an orthopaedic surgeon

The cumulative pattern is more informative than any isolated HR. A patient with several metabolic disorders may have a different biological risk profile from someone with a similar fracture and no such comorbidities. Risk assessment should therefore extend beyond a simple diabetes yes/no classification.

These findings support documenting metabolic burden when discussing prognosis and planning follow-up. They are also consistent with careful optimisation of glycaemic control and general metabolic health, but no optimisation intervention was tested in this study.

Limitations

• This retrospective observational study demonstrates associations, not causation.
• Results depend on the accuracy of diagnostic and outcome coding in a large clinical data network.
• The public abstract provides limited detail on fracture morphology, soft tissues, fixation and longitudinal disease control.
• Hypertension and dyslipidaemia may partly mark a broader metabolic phenotype rather than directly cause nonunion.
• The findings concern surgically treated tibial shaft fractures and cannot automatically be transferred to other bones or fracture types.

Implications for practice

Metabolic burden, particularly the number of concurrent disorders, merits consideration in formal nonunion risk assessment. The analysis does not show that reducing blood pressure, body weight or lipids after a fracture reduces nonunion risk in proportion to the reported HRs. It establishes no threshold for changing fixation, weight-bearing progression or routinely adding biological treatments.

This is prognostic evidence rather than an interventional trial. Union still reflects the interaction of biology, mechanics, injury characteristics and treatment; metabolic phenotype is one part of that assessment.

References

Kotzur T, Peterson B, McCoy L, Pereira DE, Hosseinzadeh P, Martin C. Metabolic Derangements Are Independent Additive Risk Factors for Tibial Diaphyseal Nonunion. Journal of Orthopaedic Trauma. 2026;40(9):473–481. DOI: 10.1097/BOT.0000000000003202. PubMed: PMID 42048121.

This summary is based on the public abstract and PubMed metadata.

Related resources

For Doctors and Physiotherapists · Research Updates, Literature and Evidence-Based Medicine

Content prepared by: Tomasz Poboży - orthopaedic surgeon.